THIS HAS HAD A DIRECT IMPACT ON OUR SERVICE OFFERING
With our Global Tactical Asset Allocation (GTAA) model as basis, and with the links to global grandmaster and local master level asset managers as our preferred partners, we could easily have created a broad-market, global specialization.
But this is not the market segment where institutional parties were waiting for us as new kid on the block during the last 10-15 years. There are plenty of good global ‘backbone’ asset managers out there. And it is our philosophy anyway to use these grandmasters in our solutions where possible. And that is what we do.
To the extent that institutional or UHNW end investors require the global component in their solution, Parmenion will help them out. We are independent and will often come up with solutions in which multiple global grandmaster managers will together – together with some amazing local niche players – give you the best tailor-made solution for you. Often without extra costs, because we can in many cases provide you with solutions in which we get discounted prices when incorporating them into our fund solution.
And this is actually quite logical. Many Western institutional investors are still underinvested in EMFM that are – because of higher growth levels – increasing their global weights.
The fact that we are now part of a Chinese group is not coincidental. First, our approach fits nicely with expansion in EMFM markets, where more and more investors are now eyeing international diversification. But also because we finally see international investors now believing that the growing opportunities in China, India and other Emerging and Frontier countries are here to stay.
Parmenion believes that it can be your gateway whenever you want to diversify your portfolio into EMFM.
Golden Partner Group has its origin in China and with offices and representation in Hong Kong and Singapore, GP Parmenion believes that our partnership with GP Group strengthens not just our concept, but also our business opportunities in Asia-Pacific in general and China in particular.
We already witness this through growing interest in our B2B solutions (GP Parmenion as sub-advisor to financial services providers who run their own fund and other solutions with us providing them with investment expertise based on our concept), but also through the direct creation of Asian solutions. Regarding the latter it is probably no surprise that we started with a China product range together with GP Shanghai.
Parmenion believes that this trend is irreversible and that China (and in its slipstream India) is here to stay and gain market share.
As an example: the Chinese stock market already lists more than 3,500 stocks and together with Chinese companies listed abroad the spectrum reaches almost 4,000 stocks with an average market capitalization of about USD 1 billion.
Not just will we offer our Chinese strategies to institutional clients/prospects in Europe, MENA and selected other countries, we also believe that – supported by our colleagues from the GP Shanghai office – China will develop into a new hub for Parmenion products.